Atlas Trials

The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence

Clinical trial NCT03209206 · UNKNOWN

Trial details

NCT number
NCT03209206
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Urothelial Carcinoma
Start date
2017-06-28
Primary completion
2020-06-19
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.